{"slug":"ss-31-cognition","verification":{"valid":true,"entries":2,"head":"573a8d8735cf315d9b95257e3b2c1cd5bfa4ca873a0d9a70bd9690ad1b586407"},"energy":{"passes":2,"tokens_in":15475,"tokens_out":3017,"tokens_total":18492,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"573a8d8735cf315d9b95257e3b2c1cd5bfa4ca873a0d9a70bd9690ad1b586407"},"provenance":[{"ts":"2026-06-29T23:57:01.204Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Cognition\nSlug: ss-31-cognition\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down\",\"Why SS-31 (Elamipretide) might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not me","response":"{\n  \"slug\": \"ss-31-cognition\",\n  \"title\": \"SS-31 (Elamipretide) for Cognition: Mitochondrial Evidence Graded\",\n  \"body\": \"## What's breaking down\\n\\nCognition depends on neurons having steady energy from mitochondria. When those organelles lose cardiolipin stability, electron transport leaks, reactive oxygen species rise, and ATP drops. Synapses weaken. Inflammation can follow. Over time the repair side falls behind the daily wear, and memory, focus, or processing speed show it. No single drug masks that; repair at the mitochondrial membrane is what gets discussed for this layer.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\nSS-31 binds cardiolipin in the inner mitochondrial membrane.\\n\\n1. If your neurons have excess ROS from leaky mitochondria, the peptide is studied because it stabilizes cardiolipin and lowers electron leak.\\n2. If ATP production is down, the same stabilization supports complex activity and ATP output in preclinical models.\\n3. If synaptic proteins are declining, reduced oxidative damage and better energy are the pathways linked to preserved dendritic spines and memory performance in animal work.\\n4. Therefore for you: If mitochondrial dysfunction sits at the root of your cognitive layer, SS-31 is discussed because it targets repair at the membrane — not because it suppresses symptoms.\\n\\n## How these fit together\\n\\nSingle-compound focus. SS-31 maps to the mitochondrial layer. If your profile includes other degeneration layers, separate compounds would address those; this one stays on cardiolipin stabilization and downstream energy/ROS effects.\\n\\n## What the evidence actually shows\\n\\nPreclinical only for cognition. No human trials test SS-31 on memory, executive function, or dementia endpoints. All listed studies used rodents.\\n\\n- In one mouse study, lipopolysaccharide triggered hippocampal mitochondrial dysfunction, oxidative stress, synaptic loss, and impaired Morris water maze and fear conditioning performance. SS-31 treatment reduced t","tokens_in":15475,"tokens_out":3017,"cost":0,"prev":"genesis","hash":"ba3059333609ca76d8ba75260258ce28e54fc2a1a34cd2999e1e359cfae53808"},{"ts":"2026-07-17T02:42:02.174Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-cognition","response":"21 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ba3059333609ca76d8ba75260258ce28e54fc2a1a34cd2999e1e359cfae53808","hash":"573a8d8735cf315d9b95257e3b2c1cd5bfa4ca873a0d9a70bd9690ad1b586407"}]}